- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 68.99% based on similar historical setup states.
MCK
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
McKesson Corporation · Healthcare · Medical Distribution
Latest close
840.9 USD
-0.1%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.3% above the Trend Line and sits at 56.8% of its 52-week range. The latest completed week returned -0.1%, after a 10.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 38/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 6d.
Setup score
52
out of 100
Latest Close
840.9 USD
24 Jul 2026
1W Return
-0.1%
latest completed week
4W Return
10.1%
short-term follow-through
12W Return
3.4%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.1%
Latest completed week; four-week move 10.1%.
Indicator stack
38/56
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 68.99%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
38/100 conviction; expected move 9.4%.
News sentiment
51/100
43 relevant articles in the latest sentiment read.
Event risk
6d
Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.3% above the Trend Line and sits at 56.8% of its 52-week range. The latest completed week returned -0.1%, after a 10.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.25
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.1% over four weeks, 3.4% over 12 weeks, and 18.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.07Latest activity-pressure read.
Pressure change93.6%Four-week change in activity pressure.
Leadership-3.67Latest relative-leadership reading.
RS change68.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 90%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength61/100Blend of value, momentum, and quality. Underlying universe rank 40; rank 1 is best.
Value68/100Relative valuation strength. Underlying universe rank 33; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum67/100Medium-term price momentum. Underlying universe rank 34; rank 1 is best.
Growth85/100Revenue and earnings growth. Underlying universe rank 16; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 20.7x Price divided by trailing earnings.
- Price / sales
- 0.2x Market value relative to trailing revenue.
- EV / EBITDA
- 14.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 6.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 3.6% Gross profit retained from each unit of revenue.
- Operating margin
- 1.6% Operating profit retained from revenue.
- Free-cash-flow margin
- 1.6% Free cash flow generated from revenue.
- Return on invested capital
- 209.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 12.4% Latest one-year revenue growth.
- EPS growth
- 44.5% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -5.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.4% Cash dividends relative to market value.
- Buyback yield
- 4.7% Net share repurchases relative to market value.
- Shareholder yield
- 5.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
MCK shows bullish options pressure with a 38/100 conviction score, put-call volume ratio of 0.29, expected move of 9.4%, and Sharemaestro trend signal inactive.
Conviction38/100
Expected move9.4%
Put/call volume0.29
Insider activity12 / 8
12 acquisitions and 8 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment51/100
Weighted news tone is neutral across 43 relevant articles.
10 positive · 27 neutral · 6 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings6dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move9.4%Nearest-chain priced movement where available.
52-week drawdown-15.7%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+14.1%Week of 6 Feb.
Worst week-9.6%Week of 8 May.
Latest week-0.1%Week of 24 Jul.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses6
Sharp losses5
Recent vol3.9%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank11 / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Distribution
4-week rank2 / 10
Group average0.0%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD60.0%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape48/100
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis10/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyPositive 68.99%Next-week expectancy is positive with a 68.99% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors51/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 12 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options41/100MCK shows bullish options pressure with a 38/100 conviction score, put-call volume ratio of 0.29, expected move of 9.4%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 9.4% Sentiment51/100Weighted news tone is neutral across 43 relevant articles.
Mckesson Corp (MCK) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders12 / 812 acquisitions and 8 disposals in the latest 180-day insider tape.
Earnings6dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 840.9 USD | -0.1% | 838.0 USD | 639.5 USD | -0.07 | -3.67 | 3.8M | Off |
| 17 Jul 2026 | 841.4 USD | 4.4% | 837.5 USD | 636.6 USD | -0.28 | -4.16 | 4.8M | Off |
| 10 Jul 2026 | 806.0 USD | 2.5% | 836.8 USD | 633.9 USD | -0.63 | -9.62 | 4.9M | Off |
| 3 Jul 2026 | 786.3 USD | 3.0% | 837.0 USD | 631.3 USD | -0.85 | -10.74 | 5.4M | Off |
| 26 Jun 2026 | 763.5 USD | 1.7% | 837.7 USD | 628.9 USD | -1.04 | -11.60 | 7.0M | Off |
| 19 Jun 2026 | 750.6 USD | -4.3% | 841.5 USD | 626.7 USD | -1.10 | -15.35 | 5.0M | Off |
| 12 Jun 2026 | 784.0 USD | 1.1% | 845.3 USD | 624.5 USD | -1.03 | -11.07 | 3.8M | Off |
| 5 Jun 2026 | 775.7 USD | 4.6% | 847.1 USD | 622.0 USD | -0.97 | -11.76 | 4.5M | Off |
| 29 May 2026 | 741.6 USD | -3.1% | 849.6 USD | 619.6 USD | -0.89 | -17.94 | 6.7M | Off |
| 22 May 2026 | 765.2 USD | 0.7% | 851.8 USD | 617.3 USD | -0.92 | -14.44 | 7.5M | Off |
| 15 May 2026 | 759.7 USD | 3.3% | 853.0 USD | 614.8 USD | -0.96 | -14.61 | 6.1M | Off |
| 8 May 2026 | 735.3 USD | -9.6% | 853.8 USD | 612.5 USD | -0.96 | -17.45 | 8.8M | Off |
| 1 May 2026 | 813.1 USD | -1.7% | 854.6 USD | 610.2 USD | -0.91 | -6.91 | 4.5M | Off |
| 24 Apr 2026 | 827.2 USD | -4.4% | 852.1 USD | 607.3 USD | -0.79 | -4.61 | 4.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.